← SynDRA
A-205804
SynDRA canonical compound SYN0062951 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ICAM1 | SELE |
|---|
| Mechanism of action | ICAM1 expression inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ALOX15B
- EHMT2
- GBA1
- HSPA5
- KAT2A
- MAPT
- SAMHD1
- TDP1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- UNII-TP7TB1SSZD
- 4-[(4-methylphenyl)thio]thieno[2,3-c]pyridine-2-carboxamide
- TP7TB1SSZD
- 4-((4-Methylphenyl)thio)thieno(2,3-C)pyridine-2-carboxamide
- RefChem:108357
- DTXCID40102355
- 4-(p-tolylthio)thieno[2,3-c]pyridine-2-carboxamide
- MFCD09038566
- A205804
- 4-(p-Tolylsulfanyl)thieno[2,3-c]pyridine-2-carboxamide
- orb1305886
- SCHEMBL7057661
- CHEBI:114180
- HMS3269O07
- HMS3413F09
- HMS3651P04
- HMS3677F09
- EX-A1788
- BDBM50098512
- s2885
- AKOS024457147
- CCG-267472
- NCGC00167761-01
- NCGC00167761-02
- NCGC00167761-04
- AC-33049
- AS-71317
- DA-35361
- SY235301
- HY-100226
- CS-0018356
- SW219899-1
- T2254
- D83118
- F862263
- BRD-K77627880-001-01-6
- BRD-K77627880-001-03-2
- BRD-K77627880-001-04-0
Look up A-205804 in the interactive SynDRA portal →